Workflow
能源国企及其董事长,被责令限期整改!

Core Viewpoint - China Energy Engineering Group Co., Ltd. (referred to as "China Energy") and its chairman Liu Bin received a warning letter from the Gansu Securities Regulatory Bureau due to violations related to information disclosure and non-operating fund occupation [1][2]. Summary by Sections Violations Identified - China Energy failed to disclose related parties and transactions involving its former controlling shareholder, Gansu Blue Science Petrochemical High-tech Equipment Co., Ltd. (referred to as "Blue Science High-tech"), leading to undisclosed amounts of 44.7643 million yuan and 72.36 million yuan in the annual reports for 2019 and 2020 respectively [1]. - The company was found to have non-operating occupation of funds, where Blue Science High-tech paid a total of 47 million yuan to related suppliers, but the funds were actually used by China Energy from August 2019 to June 2020, violating regulations on related party transactions [1]. Responsibilities and Consequences - Liu Bin, as the chairman, was aware of the relationship with Jiangsu Engao Industrial Technology Research Institute Co., Ltd. and was responsible for the related contracts and fund transfers, thus bearing primary responsibility for the violations [2]. - The Gansu Securities Regulatory Bureau decided to issue a warning letter and required the company to submit a written rectification report within 30 days of receiving the decision [2]. Company Background - China Energy was established in August 1987 and is a comprehensive energy service group under China National Machinery Industry Corporation, involved in energy investment, engineering construction, technology research and development, and energy trading services [3]. - The company is headquartered in Shanghai and possesses various qualifications and certificates across multiple sectors, including power, petrochemicals, pharmaceuticals, construction, and municipal engineering, providing integrated services from planning consultation to operational management [3].